Skip to main content


Figure 2 | Clinical and Molecular Allergy

Figure 2

From: Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab

Figure 2

Change in FcεRI expression during treatment with omalizumab. Whole blood was collected from the patient prior to the first treatment with omalizumab (day 0) and prior to each subsequent treatment day. Total FcεRI expression was examined in whole blood by flow cytometry using dual staining with basophil cell surface markers anti-CD123 (IL-3r) and anti-FcεRI.

Back to article page